Flemming Ørnskov

Flemming Ørnskov is a Danish businessman, who has been the chief executive officer (CEO) of Shire plc, a FTSE 100 speciality biopharmaceutical company, since 30 April 2013, succeeding Angus Russell.[1] He previously worked for Bayer.

References

  1. ↑ "Shire chief finds right prescription for growth". The Telegraph. Retrieved 20 March 2014.